Sale!

Current Diagnosis and Treatment Cardiology (5th Edition)

Download Current Diagnosis and Treatment Cardiology (5th Edition) written by Michael H. Crawford in PDF format. This book is under the category Cardiology and bearing the isbn/isbn13 number 1259641252; 1259641260/9781259641251/ 9781259641268. You may reffer the table below for additional details of the book.

$19.99

Specifications

book-author

Michael H. Crawford

publisher

McGraw-Hill Education / Medical; 5th edition

file-type

PDF

pages

640 pages

language

English

asin

B06WWK4DFX

isbn10

1259641252; 1259641260

isbn13

9781259641251/ 9781259641268


Book Description

Current Diagnosis and Treatment Cardiology; fifth Edition; (PDF) is a short; authoritative compilation of the important data wanted to diagnose and deal with heart problems

  • Organized for ease of use; velocity and medical performance
  • Focus on should-know info makes it excellent for board evaluate
  • Over 200 illustrations; together with ECGs; imaging research; graphs; drawings and charts
  • 37 chapters embody the main illness entities and therapeutic challenges in cardiology as we speak
  • Every chapter is written by consultants in that space; with out dropping the coherence or readability present in single-writer textbooks
  • Chapters on main administration points like coronary heart illness and being pregnant; the perioperative analysis of coronary heart illness sufferers and using anticoagulants in coronary heart illness.
  • NEW MATERIAL on the up-to-date hypertension pointers; new oral anticoagulants; new therapies for dyslipidemia administration; and new antiplatelet and antithrombotic medication
  • Logically structured into six sections: Prevention of Cardiovascular Disease; Valvular Disease; Ischemic Heart Disease; Arrhythmias; Heart Failure and Cardiomyopathy; and Systemic Disease and the Heart
  • An important fast reference for skilled physicians on the ward or within the clinic; cardiology fellows; college students and residents; technician nurses; and different well being care workers who present look after the cardiology affected person

NOTE: The product solely contains the ebook; Current Diagnosis and Treatment Cardiology fifth Edition in PDF. No access codes are included.

book-author

Michael H. Crawford

publisher

McGraw-Hill Education / Medical; 5th edition

file-type

PDF

pages

640 pages

language

English

asin

B06WWK4DFX

isbn10

1259641252; 1259641260

isbn13

9781259641251/ 9781259641268

Table of contents


Table of contents :
Title Page……Page 2
Copyright Page……Page 3
Contents……Page 5
Authors……Page 34
Preface……Page 42
Lipoproteins and Apolipoproteins……Page 43
Metabolism……Page 44
Clinical Findings……Page 46
Secondary Causes of Dyslipidemia……Page 47
groups of patients who would benefit from statintherapy based exclusively on evidence from available randomized controlled trials. These four groups areas follows:……Page 48
Table 1–2. LDL and Non-HDL Treatment Goals……Page 50
Nonpharmacologic Treatment……Page 51
Pharmacologic Treatment……Page 52
Treatment in Specific Patient Populations……Page 54
Prognosis……Page 55
Pathophysiology & Etiology……Page 56
BP Measurement……Page 57
Symptoms & Signs……Page 58
Differential Diagnosis……Page 59
Renal Parenchymal Disease……Page 60
Pheochromocytoma……Page 61
Pharmacologic Intervention……Page 62
Management of Uncomplicated Hypertension……Page 67
Management of Hypertensive Crisis……Page 68
Management of Resistant Hypertension……Page 71
Prognosis……Page 73
Role of Platelets in Thrombosis……Page 74
Classification of Antiplatelet Drugs……Page 75
Cyclooxygenase Inhibitors: Aspirin……Page 76
P2Y12 Receptor Blockers……Page 77
GP IIbIIIa Inhibitors……Page 78
Thrombin Receptor Antagonists……Page 79
Special Populations……Page 80
Anticoagulants……Page 82
Risks of Anticoagulant Therapy……Page 85
Pathogenesis of Intravascular Thrombi……Page 86
Diagnostic Studies……Page 87
Atrial Fibrillation……Page 91
Native Valvular Heart Disease……Page 97
Prosthetic Heart Valves……Page 99
Left Ventricular Thrombus……Page 102
Pacemakers, Implantable Cardioverter-Defibrillators, and Other Intracardiac Devices……Page 104
Interruption of Anticoagulation for Surgery and Invasive Procedures……Page 106
Common Symptoms……Page 109
Physical Examination……Page 111
Diagnostic Studies……Page 117
Pathophysiology & Etiology……Page 128
Risk Factors……Page 129
Symptoms & Signs……Page 130
Physical Examination……Page 131
Diagnostic Studies……Page 132
Choosing a Diagnostic Approach……Page 135
General Approach……Page 136
Pharmacologic Therapy……Page 137
Revascularization……Page 143
Selection of Therapy……Page 144
Prognosis……Page 146
Background……Page 148
Symptoms……Page 149
Diagnostic Studies……Page 150
Acute Myocardial Infarction……Page 152
Other Causes of Chest Pain……Page 153
Initial Management……Page 154
Definitive Management……Page 161
Prognosis……Page 162
General Considerations……Page 164
Pathophysiology & Etiology……Page 165
Symptoms & Signs……Page 166
Physical Examination……Page 167
Diagnostic Studies……Page 168
Prehospital Management……Page 172
Emergency Department Therapy……Page 173
Reperfusion Therapy……Page 175
Primary Percutaneous Coronary Intervention Versus Fibrinolysis……Page 178
Fibrinolytic Agents……Page 179
Adverse Effects of Fibrinolytic Therapy……Page 182
Cardiogenic Shock……Page 183
Congestive Heart Failure……Page 184
Cardiac Rupture……Page 185
Pericarditis……Page 186
Conduction Disturbances……Page 187
Other Arrhythmias……Page 188
Mural Thrombi……Page 189
Aneurysms and Pseudo-Aneurysms……Page 190
Risk Predictors……Page 191
Risk Assessment……Page 192
Risk Management……Page 193
Etiology……Page 196
Pathogenesis……Page 197
Cardiogenic Shock after Acute MI……Page 198
Mechanical Complications of Acute MI……Page 199
Right Ventricular Infarction……Page 200
Physical Examination……Page 201
Diagnostic Studies……Page 202
Treatment……Page 203
Acute Myocardial Infarction……Page 204
Mechanical Complications……Page 207
Arrhythmias……Page 208
Prognosis……Page 209
Preoperative Risk Assessment……Page 210
Algorithms……Page 211
Intermediate-Risk Patients……Page 212
Understanding Cardiac Complications……Page 213
Aspirin……Page 214
Perioperative Medication Management……Page 215
Prophylactic Coronary Revascularization……Page 217
Severe Valvular Disease……Page 218
Pacemakers, Defibrillators, & Atrial Fibrillation……Page 219
General Considerations……Page 221
Pathophysiology & Etiology……Page 223
General Diagnostic Approach……Page 224
General Considerations……Page 226
Treatment……Page 227
Clinical Findings……Page 228
Conversion……Page 229
Multifocal Atrial Tachycardia……Page 230
Treatment……Page 231
General Considerations……Page 232
Pharmacologic Therapy……Page 233
General Considerations……Page 234
Pathophysiology……Page 235
Catheter Ablation……Page 237
Clinical Findings……Page 238
Anatomy……Page 240
Atrioventricular Reciprocating Tachycardia……Page 239
Cardiac Electrical Conduction……Page 241
Mechanism……Page 246
Pharmacologic Therapy……Page 249
Radiofrequency Catheter Ablation Therapy……Page 250
Other Bypass Tracts……Page 251
Differentiation of Wide QRS Complex Tachycardias……Page 252
Wandering Atrial Pacemaker……Page 253
Treatment……Page 254
General Considerations……Page 255
Symptoms & Signs……Page 256
Differential Diagnosis……Page 257
Rate Control……Page 258
Long-Term Antiarrhythmic Therapy and Elective Cardioversion……Page 259
Antiarrhythmic Drug Therapy for Atrial Fibrillation……Page 260
Anticoagulant Therapy……Page 262
Direct-Current Cardioversion……Page 264
Long-Term Approach……Page 265
Nonpharmacologic Treatment of Atrial Fibrillation……Page 267
Prognosis……Page 268
Underdiagnosis……Page 269
Diagnostic Approach to the Patient with Wide QRS Complex Tachycardia……Page 270
Atrioventricular Relationship……Page 273
QRS Complex Duration……Page 274
QRS Complex Axis……Page 275
History, Physical Examination, & 12-Lead Electrocardiogram……Page 276
Classifications of Ventricular Tachycardia……Page 277
Monomorphic Ventricular Tachycardia in Association with Chronic Coronary Artery Disease……Page 278
Monomorphic Ventricular Tachycardia in Association with Idiopathic Dilated Cardiomyopathy……Page 279
Monomorphic Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy……Page 280
Ventricular Tachycardia Not Associated with Structural Heart Disease……Page 283
Idiopathic Left Ventricular Tachycardia or Fascicular Ventricular Tachycardia……Page 284
Outflow Tract Ventricular Tachycardia……Page 285
Ventricular Tachycardia Arising from Cardiac Crux……Page 287
Diagnostic Studies……Page 288
Immediate Termination……Page 289
Pharmacologic Therapy……Page 290
Nonpharmacologic Therapy……Page 291
Clinical Findings……Page 292
Polymorphic Ventricular Tachycardia with a Normal QT Interval……Page 295
Prognosis……Page 297
General Considerations……Page 298
Sinus Node Dysfunction……Page 299
Atrioventricular Block……Page 305
Symptoms & Signs……Page 306
Physical Examination……Page 308
Diagnostic Studies……Page 309
Treatment……Page 321
Cardiac Pacing……Page 323
Pacing System Malfunctions……Page 341
Assessment of Pacing System Function……Page 344
General Considerations……Page 347
Coronary Artery Disease……Page 348
Nonischemic Dilated Cardiomyopathy……Page 350
Inherited Arrhythmia Syndromes……Page 351
Management of Cardiac Arrest: Initial Resuscitation……Page 353
Complications of Resuscitation……Page 354
Diagnostic Studies……Page 356
Antiarrhythmic Drug Therapy……Page 358
Surgical or Catheter Ablation……Page 359
Implantable Cardioverter-Defibrillators……Page 360
Risk Assessment Studies……Page 362
Primary Prevention of Sudden Death……Page 363
Pathophysiology & Etiology……Page 366
Reflex or Neurally Mediated Syncope (NMS)……Page 367
Cardiac Syncope……Page 368
Clinical Findings……Page 369
Symptoms & Signs……Page 370
Risk Stratification……Page 371
Diagnostic studies……Page 372
Noninvasive Diagnostic Investigations……Page 373
Differential Diagnosis……Page 374
Psychiatric Disorders and Pseudosyncope……Page 375
Neurally Mediated Reflex Syncope……Page 376
Prognosis……Page 378
Clinical Perspective……Page 379
General Considerations & Etiology……Page 380
History……Page 381
Physical Examination……Page 383
Diagnostic Dilemmas: Area-Gradient Mismatch……Page 384
Normal EF Area-Gradient Mismatch……Page 390
Reverse Area-Gradient Mismatch……Page 391
Treatment……Page 392
Valve Replacement……Page 393
Special Circumstances……Page 394
Normal EF Area-Gradient Mismatch (PLF/LG Aortic Stenosis)……Page 399
Prognosis……Page 400
Etiology……Page 402
Clinical Findings……Page 403
Symptoms & Signs……Page 404
Diagnostic Studies……Page 405
Acute Aortic Regurgitation……Page 411
Chronic Aortic Regurgitation……Page 412
Prognosis……Page 414
General Considerations……Page 416
Anatomy……Page 417
Etiology……Page 418
Pathophysiology……Page 420
Clinical Findings……Page 423
Physical Examination……Page 424
Electrocardiography……Page 425
Chest Radiography……Page 426
Echocardiography……Page 427
Cardiac Computed Tomography and Magnetic Resonance Imaging……Page 434
Cardiac Catheterization……Page 435
Treatment……Page 437
Interventional Therapy……Page 438
Prognosis……Page 441
General Considerations……Page 442
Physical Examination……Page 444
Diagnostic Studies……Page 447
Differential Diagnosis……Page 451
Valve Repair or Replacement……Page 452
Prognosis……Page 455
General Considerations……Page 456
Tricuspid Regurgitation……Page 457
Symptoms & Signs……Page 459
Physical Examination……Page 460
Diagnostic Studies……Page 463
Surgical……Page 470
General Considerations……Page 472
Pulmonic Stenosis……Page 473
Diagnostic Studies……Page 474
Treatment……Page 475
Prognosis……Page 476
Cardiac Infection—Vegetations……Page 477
Clinical Syndromes……Page 479
Clinical Findings……Page 484
Symptoms & Signs……Page 485
Physical Examination……Page 486
Diagnostic Studies……Page 488
Antibiotic Therapy……Page 492
Management of Complications……Page 494
Management of High-Risk Endocarditis……Page 497
Surgery……Page 498
Follow-Up After Endocarditis……Page 499
Definition & Prevalence……Page 501
Genetics & Histopathology……Page 502
Pathophysiology……Page 503
Diastolic Dysfunction……Page 504
Outflow Obstruction/Systolic Anterior Motion……Page 505
Mitral Regurgitation……Page 508
Myocardial Ischemia……Page 509
Diagnostic Tests……Page 510
Diagnostic Considerations in Hypertrophic Cardiomyopathy Variants……Page 519
Nonpharmacologic Therapies……Page 522
Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy……Page 524
Hypertrophic Cardiomyopathy and Athlete’s Heart……Page 525
Special Considerations in Hypertrophic Cardiomyopathy……Page 526
Overview……Page 527
Pertinent Aspects of Normal Hemodynamics……Page 529
Pathophysiology……Page 530
Myocardial Disorders……Page 533
Endomyocardial Disease……Page 535
Differentiating Restrictive Cardiomyopathy from Other Disorders……Page 536
Clinical Algorithms to Differentiate Constriction from Restriction……Page 538
Treatment……Page 539
Prognosis……Page 540
Pathophysiology……Page 541
Symptoms & Signs……Page 542
Diagnostic Studies……Page 544
Treatment……Page 546
Chagas Disease……Page 547
Cardiac Sarcoidosis……Page 548
Toxic Cardiomyopathy……Page 549
Diagnostic Studies……Page 550
Treatment……Page 551
Alcoholic Cardiomyopathy……Page 552
Chemotherapy-Induced Cardiomyopathy……Page 553
Trace Element–Related Cardiomyopathy……Page 554
Physical Examination……Page 555
Diagnostic Studies……Page 556
Treatment……Page 557
Prognosis……Page 558
General Considerations……Page 559
Pathophysiology……Page 560
Physical Examination……Page 564
Laboratory Testing……Page 566
Diagnostic Studies……Page 567
Prevention……Page 569
Nonpharmacologic Treatment……Page 571
Pharmacologic Treatment: Life-Saving Therapies……Page 572
Pharmacologic Treatment: Symptomatic Therapies……Page 576
Pharmacologic Treatment: Other Therapies……Page 578
Electrical Treatment……Page 580
Surgical Treatment……Page 581
Prognosis……Page 583
HFpEF is the preferred term for……Page 585
Diastolic Dysfunction……Page 586
Left Ventricular Remodeling……Page 587
Chronotropic Incompetence……Page 588
Endothelial Dysfunction……Page 589
Symptoms & Signs……Page 590
Diagnostic Studies……Page 591
Differential Diagnosis……Page 596
Prevention……Page 598
Nonpharmacologic Therapy……Page 599
Pharmacologic Therapy……Page 600
Prognosis……Page 606
Etiology & Pathogenesis……Page 607
Infectious Pathogens……Page 608
Iatrogenic Causes……Page 609
Connective Tissue Disorders……Page 610
Other Causes……Page 611
Physical Examination……Page 613
Diagnostic Studies……Page 614
Treatment……Page 616
Physical Examination……Page 620
Diagnostic Studies……Page 621
Cardiac Tamponade……Page 624
Symptoms & Signs……Page 625
Diagnostic Studies……Page 626
Treatment……Page 627
General Considerations……Page 628
Diagnostic Studies……Page 629
Differential Diagnosis……Page 631
Treatment……Page 633
Effusive-Constrictive Pericarditis……Page 635
General Considerations……Page 636
Thrombophilia……Page 637
Clinical Findings……Page 638
Symptoms & Signs……Page 639
Diagnostic Studies……Page 641
Nonpharmacologic Prevention……Page 647
Pharmacologic Prevention……Page 648
Future Directions……Page 649
Risk Stratification……Page 650
Treatment……Page 651
Low-Molecular-Weight Heparin……Page 652
Fondaparinux……Page 654
Thrombolysis……Page 655
Warfarin……Page 657
Adjunctive Measures……Page 658
Venous Thromboembolism in Pregnancy……Page 659
Counseling……Page 660
30. Pulmonary Hypertension……Page 662
Classification & Pathogenesis……Page 663
Pulmonary Arterial Hypertension……Page 664
Pulmonary Hypertension Associated with Lung Diseases and Hypoxemia……Page 668
Chronic Thromboembolic Pulmonary Hypertension……Page 669
Right Ventricular Failure Resulting from Pulmonary Hypertension……Page 670
Symptoms & Signs……Page 672
Diagnostic Studies……Page 673
Differential Diagnosis……Page 680
Pulmonary Arterial Hypertension……Page 682
Pulmonary Hypertension with Left-Sided Heart Disease……Page 692
Pulmonary Hypertension due to Chronic Thrombotic or Embolic Disease……Page 693
Prognosis……Page 694
Acyanotic Congenital Heart Disease……Page 696
Symptoms & Signs……Page 697
Diagnostic Studies……Page 698
Differential Diagnosis……Page 700
Prognosis & Treatment……Page 701
Pulmonary Valve Stenosis……Page 702
Symptoms & Signs……Page 703
Diagnostic Studies……Page 704
Prognosis & Treatment……Page 706
Atrial Septal Defect……Page 707
General Considerations……Page 708
Symptoms & Signs……Page 709
Diagnostic Studies……Page 710
Prognosis & Treatment……Page 714
Ventricular Septal Defects……Page 715
General Considerations……Page 716
Diagnostic Studies……Page 717
Prognosis & Treatment……Page 719
Patent Ductus Arteriosus……Page 720
General Considerations……Page 721
Diagnostic Studies……Page 722
General Considerations……Page 723
Symptoms & Signs……Page 724
Diagnostic Studies……Page 725
Prognosis & Treatment……Page 727
General Considerations……Page 728
Symptoms & Signs……Page 729
Diagnostic Studies……Page 730
General Considerations……Page 732
Diagnostic Studies……Page 734
Other Acyanotic Congenital Defects……Page 737
Cyanotic Congenital Heart Disease……Page 739
Tetralogy of Fallot & Pulmonary Atresia with Ventricular Septal Defect……Page 740
General Considerations……Page 741
Diagnostic Studies……Page 742
Prognosis & Treatment……Page 745
General Considerations……Page 746
Diagnostic Studies……Page 747
Transposition of the Great Arteries……Page 751
General Considerations……Page 752
Symptoms & Signs……Page 753
Prognosis & Treatment……Page 754
General Considerations……Page 755
Symptoms & Signs……Page 756
Diagnostic Studies……Page 757
General Considerations……Page 758
Prognosis & Treatment……Page 759
Palliative Surgical Procedures……Page 760
Medical Therapy in Patients with Systemic Right Ventricle……Page 761
Prevention of Infective Endocarditis……Page 762
Recommendations For Exercise & Sports Participation……Page 764
Acquired Heart Disease in Adults with Congenital Heart Disease……Page 765
General Considerations……Page 766
Benign Cardiac Tumors……Page 767
Malignant Cardiac Tumors……Page 775
Benign or Malignant Cardiac Tumors……Page 777
Secondary Cardiac Tumors: The Far-Roaming Settlers……Page 779
Clinical Findings……Page 780
Symptoms & Signs……Page 781
Diagnostic Studies……Page 782
Echocardiography……Page 783
Magnetic Resonance Imaging……Page 785
Positron Emission Tomography……Page 786
Differential Diagnosis……Page 787
Normal Variant Structures……Page 788
Thrombus……Page 789
Caseous Calcification of the Mitral Annulus……Page 790
Calcified Amorphous Tumor……Page 791
Surgery……Page 792
Radiation……Page 794
Prognosis……Page 795
General Considerations……Page 797
Cardiac Output……Page 798
Congenital Heart Disease……Page 799
Valvular Heart Disease……Page 804
Myocarditis……Page 807
Cardiomyopathy……Page 808
Coronary Artery Disease……Page 810
Arrhythmias……Page 811
Pericardial Diseases……Page 813
Pulmonary Hypertension……Page 814
Diseases of the Aorta……Page 815
Hypertension……Page 816
Physical Examination……Page 817
Diagnostic Studies……Page 818
Pharmacologic Treatment……Page 821
Labor & Delivery……Page 824
Prognosis……Page 825
Thyroid & the Heart……Page 826
Hyperthyroidism……Page 827
General Considerations……Page 828
Symptoms & Signs……Page 829
Diagnostic Studies……Page 831
Treatment……Page 832
General Considerations……Page 834
Diagnostic Studies……Page 835
Treatment……Page 836
Effect of Heart Disease on Thyroid Function……Page 837
Cardiovascular Drugs & the Thyroid……Page 838
Hyperparathyroidism……Page 839
Symptoms & Signs……Page 840
Treatment & Prognosis……Page 841
Hypoparathyroidism……Page 842
General Considerations……Page 843
Diagnostic Studies……Page 844
Treatment……Page 846
Prognosis……Page 847
Symptoms & Signs……Page 848
Treatment……Page 849
Diagnostic Considerations……Page 850
General Considerations……Page 851
Diagnostic Considerations……Page 852
General Considerations……Page 853
Physical Examination……Page 854
Growth Hormone Deficiency……Page 855
General Considerations……Page 856
General Considerations……Page 857
Treatment……Page 858
Effects of Diabetes on Peripheral Vascular Disease……Page 860
Hormone Replacement Therapy……Page 861
Oral Contraceptives……Page 862
General Considerations……Page 864
General Considerations……Page 865
Valve Vegetations, or Libman-Sacks Endocarditis……Page 866
Symptoms & Signs……Page 869
Diagnostic Studies……Page 870
General Considerations……Page 871
Diagnostic Studies……Page 872
General Considerations……Page 873
Diagnostic Studies……Page 874
General Considerations……Page 875
Other Therapy……Page 876
Symptoms & Signs……Page 877
Other Therapy……Page 878
Prognosis……Page 879
General Considerations……Page 880
Laboratory Findings……Page 881
Prognosis……Page 882
General Considerations……Page 883
Diagnostic Studies……Page 884
General Considerations……Page 885
Diagnostic Studies……Page 886
General Considerations……Page 887
Diagnostic Studies……Page 888
Prognosis……Page 889
General Considerations……Page 890
Treatment & Prognosis……Page 891
Scleroderma……Page 892
Pathophysiology……Page 893
Diagnostic Studies……Page 894
Treatment……Page 895
Diagnostic Studies……Page 896
General Considerations……Page 897
Prognosis……Page 898
Prognosis……Page 899
Secondary Scleroderma Heart Disease……Page 900
General Considerations……Page 902
Diagnostic Studies……Page 903
Medical Therapy……Page 904
Physical Examination……Page 905
Myocardial Disease, Atherosclerosis, & Pericardial Disease……Page 906
Polymyositis/Dermatomyositis……Page 907
Myocarditis……Page 908
Valvular Heart Disease……Page 909
Treatment & Prognosis……Page 910
Symptoms & Signs……Page 911
Treatment……Page 912
Prognosis……Page 913
Physiology of Exercise Training……Page 914
Chamber Morphologic Adaptations to Endurance Training……Page 915
Medical History & Physical Examination……Page 917
Diagnostic Studies……Page 919
Preparticipation Screening……Page 923
Recommendations for Sport Participation……Page 924
General Considerations……Page 925
Etiology……Page 927
Natural History……Page 934
Physical Examination……Page 938
Diagnostic Studies……Page 939
Indications & Contraindications……Page 942
Surgical Techniques……Page 943
Specific Clinical Scenarios & Issues……Page 945
Aortic Dissection……Page 948
Terminology……Page 949
Clinical Findings……Page 952
Differential Diagnosis……Page 953
Pharmacotherapy……Page 954
Surgical Treatment……Page 955
Prognosis……Page 957
Index……Page 959

Reviews

There are no reviews yet.

Be the first to review “Current Diagnosis and Treatment Cardiology (5th Edition)”

Your email address will not be published. Required fields are marked *

Recent Posts

5 tips for a good business blog

Are you also looking for a good structure for your business blogs? That you finally have a serious and good structure for all your texts that are online? On your website but also on social media. In this review you will find 5 tips from Susanna Florie from her book: How do you…

Study tips from a budding engineer

“Why engineering?” is a question I get often. The answer for me is simple: I like to solve problems. Engineering is a popular field for many reasons. Perhaps this is because almost everything around us is created by engineers in one way or another, and there are always new, emerging and exciting technologies impacting…

How do I study mathematics and pass my exam?

Not sure how best to study math ? Are you perhaps someone who starts studying the day before the exam? Then you know yourself that your situation is not the most ideal. Unfortunately, there is no magic bullet to make you a maths crack or pass your exam in no time . It is important to know that mathematics always builds on…